Epigenetic regulation of drug metabolism and transport

被引:49
|
作者
Peng, Lai [1 ,2 ]
Zhong, Xiaobo [1 ]
机构
[1] Univ Connecticut, Sch Pharm, Dept Pharmaceut Sci, Storrs, CT 06269 USA
[2] Shanghai Jiao Tong Univ, Key Lab Syst Biomed, Ctr Comparat Biomed, Inst Syst Biomed, Shanghai 200240, Peoples R China
关键词
Drug metabolism; Dna methylation; Epigenetics; Histone modification; Non-coding RNA; Transporter; EMBRYONIC STEM-CELLS; SMALL HETERODIMER PARTNER; HUMAN PROSTATE-CANCER; DNA METHYLATION; HISTONE METHYLATION; GENE-EXPRESSION; HUMAN GENOME; DEVELOPMENTAL REGULATORS; NONCODING RNAS; VALPROIC ACID;
D O I
10.1016/j.apsb.2015.01.007
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The drug metabolism is a biochemical process on modification of pharmaceutical substances through specialized enzymatic systems. Changes in the expression of drug-metabolizing enzyme genes can affect drug metabolism. Recently, epigenetic regulation of drug-metabolizing enzyme genes has emerged as an important mechanism Epigenetic regulation refers to heritable factors of genomic modifications that do not involve changes in DNA sequence. Examples of such modifications include DNA methylation, histone modifications, and non-coding RNAs. This review examines the widespread effect of epigenetic regulations on genes involved in drug metabolism, and also suggests a network perspective of epigenetic regulation. The epigenetic mechanisms have important clinical implications and may provide insights into effective drug development and improve, safety of drug therapy. (C) 2015 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V. All rights reserved.
引用
收藏
页码:106 / 112
页数:7
相关论文
共 50 条
  • [21] Linking metabolism and epigenetic regulation in development of hepatocellular carcinoma
    Puszyk, William Matthew
    Thu Le Trinh
    Chapple, Sarah J.
    Liu, Chen
    LABORATORY INVESTIGATION, 2013, 93 (09) : 983 - 990
  • [22] Epigenetic Regulation of Gene Expression as an Anticancer Drug Target
    Ferguson, L. R.
    Tatham, A. L.
    Lin, Z.
    Denny, W. A.
    CURRENT CANCER DRUG TARGETS, 2011, 11 (02) : 199 - 212
  • [23] Epigenetic regulation of early neural fate commitment
    Qiao, Yunbo
    Yang, Xianfa
    Jing, Naihe
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2016, 73 (07) : 1399 - 1411
  • [24] Epigenetic regulation of drug transporter expression in human tissues
    Hirota, Takeshi
    Tanaka, Toshihiro
    Takesue, Hiroaki
    Ieiri, Ichiro
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2017, 13 (01) : 19 - 30
  • [25] Epigenetic regulation in obesity
    Drummond, Elaine M.
    Gibney, Eileen R.
    CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2013, 16 (04) : 392 - 397
  • [26] Epigenetic regulation of melanogenesis
    Zhou, Shihang
    Zeng, Hongliang
    Huang, Jinhua
    Lei, Li
    Tong, Xiaoliang
    Li, Si
    Zhou, Ying
    Guo, Haoran
    Khan, Manal
    Luo, Liping
    Xiao, Rong
    Chen, Jing
    Zeng, Qinghai
    AGEING RESEARCH REVIEWS, 2021, 69
  • [27] Epigenetic regulation of hematopoiesis
    Sashida, Goro
    Iwama, Atsushi
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2012, 96 (04) : 405 - 412
  • [28] Epigenetic regulation of iron metabolism and ferroptosis in Parkinson's disease: Identifying novel epigenetic targets
    Gao, Xiao-die
    Ding, Jian-e
    Xie, Jun-xia
    Xu, Hua-min
    ACTA PHARMACOLOGICA SINICA, 2025,
  • [29] How Epigenetic Modifications Drive the Expression and Mediate the Action of PGC-1α in the Regulation of Metabolism
    Kraemer, Anne I.
    Handschin, Christoph
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (21)
  • [30] Influence of toxicologically relevant metals on human epigenetic regulation
    Ryu H.-W.
    Lee D.H.
    Won H.-R.
    Kim K.H.
    Seong Y.J.
    Kwon S.H.
    Toxicological Research, 2015, 31 (1) : 1 - 9